Knoxville, TNNCT06962800Now EnrollingIRB Ready

Primary Membranous Nephropathy Clinical Trial in Knoxville, TN

Access cutting-edge primary membranous nephropathy treatment through this clinical trial at a research site in Knoxville. Study-provided care at no cost to qualified participants.

Sponsored by Biogen

Quick Self-Assessment

See if you qualify for this Knoxville location

Preparing your pre-screening questions...

Expert Care in Knoxville

Access primary membranous nephropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary membranous nephropathy treatment provided free

Apply for This Knoxville Location

Check if you qualify for this primary membranous nephropathy clinical trial in Knoxville, TN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Knoxville

    Convenient for TN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Knoxville site if eligible
  4. 4Begin participation

About This Primary Membranous Nephropathy Study in Knoxville

In this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with PMN, autoantibodies build up in the glomeruli of the kidney. Antibodies are proteins that help the body fight off infection. An autoantibody is a type of antibody that mistakenly targets and attacks the body's own tissues. Glomeruli are the filters of the kidney that remove waste and extra fluid from the body. In PMN, the build-up of autoa

Sponsor: Biogen

Who Can Participate

Inclusion Criteria

Diagnosed with PMN in need of IST according to the Investigator's clinical judgment. The diagnosis of PMN must be documented with the presence of nephrotic syndrome, and hypoalbuminemia, and confirmed with a kidney biopsy either during Screening or within 5 years of signing the informed consent form (ICF) \[see kidney biopsy exception below for participants positive for anti-PLA2R antibodies\]. For these participants, the biopsy report with redacted protected health information must be available to be reviewed by the Sponsor or an independent nephropathologist. If the participant requires a kidney biopsy during Screening, medical monitor approval must be obtained and all other eligibility criteria should be reviewed to ensure that the participant is otherwise eligible prior to performing the kidney biopsy. a. Kidney biopsy exception for anti-PLA2R antibody positive participants: Participants who are positive for anti-PLA2R antibodies and have not had a kid

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Knoxville?

Yes, this clinical trial (NCT06962800) has an active research site in Knoxville, TN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Membranous Nephropathy Treatment Options in Knoxville, TN

If you're searching for primary membranous nephropathy treatment options in Knoxville, TN, this clinical trial (NCT06962800) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Knoxville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary membranous nephropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary membranous nephropathy clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Knoxville, TN

See all rheumatoid arthritis clinical trials recruiting in Knoxville — not just this study.

Browse Rheumatoid Arthritis Trials in Knoxville →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsPulmonary Hypertension TrialsNephrotic Syndrome TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Knoxville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Knoxville, TN